Eurosirel SpA
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Eurosirel SpA - overview
Established
1975
Location
-, -, Italy
Primary Industry
Medical Devices & Equipment
About
Based in Italy, Eurosirel SpA specializes in the development and manufacturing of medical devices and cosmetic products, serving as a Contract Development and Manufacturing Organization (CDMO) for diverse clients globally. Eurosirel SpA is an Italian company founded in 1975 by Alberto Leonelli, focusing on the development and manufacturing of medical and cosmetic solutions. The company has remained committed to its core mission without significant pivots in its business strategy. It is headquartered in Italy and has established a global presence with exports to over 60 countries.
The company has been involved in 1 deal, with its most recent funding round occurring on April 30, 2024. Eurosirel specializes in a comprehensive range of medical devices and cosmetic products, offering tailored private label solutions. The product portfolio includes post-operative dressings, anti-viral patches, skincare masks, and beauty treatments aimed at pharmaceutical chains and multinational corporations in the care and beauty sector. In 2024, Eurosirel reported a revenue of EUR 72,528,391.
90 and an EBITDA of EUR 11,170,824. 40, primarily generated through B2B partnerships with leading pharmaceutical firms and retail chains. Following the recent acquisition agreement in April 2024 by Arca SGR and Alto Partners, among others, Eurosirel SpA plans to strengthen its position in the wound care sector both locally and internationally. This acquisition will support the development and launch of new products designed for specific market needs, although specific release dates have not been disclosed.
The company is also targeting expansion in new markets across Europe, North America, and Asia to further enhance its global footprint.
Current Investors
Alto Partners, Fondo Italiano d'Investimento, Finanziaria Trentina
Primary Industry
Medical Devices & Equipment
Sub Industries
Beauty & Hygiene, Medical Supplies
Website
www.eurosirel.it
Verticals
Manufacturing
Company Stage
Mature - Buyout
Total Amount Raised
Subscriber access only
Eurosirel SpA - timeline of key events
Eurosirel SpA - financials
| Fiscal Year Ended | Dec 31, 2019 | Dec 31, 2020 | Dec 31, 2021 | Dec 31, 2022 | Dec 31, 2023 | Dec 31, 2024 |
|---|---|---|---|---|---|---|
| Revenue (USD) | 41,474,610 | 45,885,500 | 50,882,395 | - | - | - |
| % Revenue Growth (YoY) | - | 10.6% | 10.9% | - | - | - |
| EBITDA (USD) | 8,442,900 | 10,055,885 | 11,414,723 | - | - | - |
| Operating Income (USD) | 7,389,171 | 8,793,622 | 9,127,256 | - | - | - |
| Operating Margin | 17.8% | 19.2% | 17.9% | - | - | - |
| % EBITDA Margin | 20.4% | 21.9% | 22.4% | - | - | - |
| NET Income (USD) | 5,297,944 | 6,335,541 | 6,662,154 | - | - | - |
| % Net Margin | 12.8% | 13.8% | 13.1% | - | - | - |
Eurosirel SpA - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Buyout | Completed | Eurosirel SpA | - |
Displaying 1 - 1 of 1
Eurosirel SpA - employee data
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.